ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Jinhong Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3354-7518; OpenAlex author ID A5102843192. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

Pancreatic Cancer-Derived Exosomes Promote the Proliferation, Invasion, and Metastasis of Pancreatic Cancer by the miR-3960/TFAP2A Axis. Co-author DOI 10.1155/2022/3590326 ↗
Is it justified to assess the resectability of pancreatic cancer combined with biological and conditional factors? Co-author DOI 10.21037/tcr-22-1258 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bingying Huang · 1 shared paper, 2022 · strength 0.15
- Paper Is it justified to assess the resectability of pancreatic cancer combined with biological and conditional factors? DOI 10.21037/tcr-22-1258 ↗
Jiangtao Li · 1 shared paper, 2022 · strength 0.15
- Paper Is it justified to assess the resectability of pancreatic cancer combined with biological and conditional factors? DOI 10.21037/tcr-22-1258 ↗
Yun Jin · 1 shared paper, 2022 · strength 0.15
- Paper Is it justified to assess the resectability of pancreatic cancer combined with biological and conditional factors? DOI 10.21037/tcr-22-1258 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.